推薦產品
等級
pharmaceutical primary standard
API 家族
modafinil
製造商／商標名
EDQM
應用
pharmaceutical (small molecule)
形式
neat
SMILES 字串
NC(=O)CS(=O)C(c1ccccc1)c2ccccc2
InChI
1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)
InChI 密鑰
YFGHCGITMMYXAQ-UHFFFAOYSA-N
基因資訊
human ... SLC6A3(6531)
尋找類似的產品？ 前往 產品比較指南
一般說明
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
應用
Modafinil EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
生化／生理作用
Modafinil is a central nervous system vigilance promoting agent, which posseses neuroprotective properties.
包裝
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
其他說明
Sales restrictions may apply.
相關產品
產品號碼
描述
訂價
訊號詞
Warning
危險聲明
危險分類
Acute Tox. 4 Oral - Repr. 2
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
Chris Neale et al.
British journal of clinical pharmacology, 75(3), 728-737 (2012-10-10)
Over recent years there has been increasing research into both pharmaceutical and nutraceutical cognition enhancers. Here we aimed to calculate the effect sizes of positive cognitive effect of the pharmaceutical modafinil in order to benchmark the effect of two widely
Cognitive enhancers are set to change workplaces.
Jacqui Wise
BMJ (Clinical research ed.), 345, e7538-e7538 (2012-11-09)
Editorial: Cognitive enhancement: are we barking up the wrong tree?
Andrew Scholey et al.
Current drug abuse reviews, 5(4), 255-256 (2012-12-21)
Modafinil #259.
Jennifer Cheng et al.
Journal of palliative medicine, 15(12), 1388-1389 (2012-12-05)
Mei-Hong Qiu et al.
PloS one, 7(9), e45471-e45471 (2012-10-03)
We have previously shown that modafinil promotes wakefulness via dopamine receptor D(1) and D(2) receptors; however, the locus where dopamine acts has not been identified. We proposed that the nucleus accumbens (NAc) that receives the ventral tegmental area dopamine inputs
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務